Oncomfort

Headquarters: Wavre, Belgium
Funding Amount: $14.7M
Select investors: Crédit Mutuel Innovation, Debiopharm Innovation Fund, Wallonia Innovation and Growth, Be Angels, BAN Vlaanderen
Oncomfort has developed a digital sedation solution for relieving patients' pain and anxiety before, during and after medical procedures. Called SedaKit, it combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality. The VR-enabled digital therapy modules are available in 12 different languages and are intended for patients aged six or more. According to the company, Sedation optimizes the use of hospital infrastructure while reducing costs and improving the quality of care.
Select partners: CHIREC Brussels Hospital, Assistance Publique - Hôpitaux de Paris, Giga Consciousness laboratory.
👥 Key people:
Highlights:
  • It works: Oncomfort's Digital Sedation has been used by more than 75,000 patients in over 100 hospitals. Also, it has been tested in 25+ studies. 🔗
  • A drug-free solution: Oncomfort Digital Sedation allows significant reduction of the use of opioids and pharmacological sedatives. It has been found to be 49% more adequate sedation than midazolam, with zero side effects or adverse events reported 🔗
  • Portable and easy-to-use: The Oncomfort Sedakit is an all-in-one portable solution that makes Digital Sedation simple, easy and accessible for both adults and children in a wide range of medical interventions.
  • Used in a range of procedures: anaesthesiology, interventional cardiology, interventional radiology, ObGyn, oncology pain management, paediatrics, surgery, dentistry emergency, geriatrics, urology, burn unit.
Last update: August 16, 2022